Here's your roundup of yesterday's announced financings, courtesy of PrivatePlacements.com, the only platform that posts every Canadian financing, every day.
1. Mind Medicine Inc. (NEO: MMED)
- Gross Proceeds: $100 million; $75 million
- Sector: Biopharmaceuticals
- Units issued: 16.67 million; 12.5 million
- Type: Common shares
- Price: $6.00
- Warrants: None
- Agents: RBC Capital Markets; Non-brokered
- Use of Proceeds: Working capital
Company breakdown:
- Clinical-stage biopharmaceutical company developing products to treat brain health disorders
- Shares recently took off in anticipation of its MM120 treatment for generalized anxiety disorder receiving breakthrough therapy designation from the US FDA
- MM120 uses lysergide, a synthetic psychedelic
Recent Articles
Apr 18, 2024
Apr 11, 2024
Mar 28, 2024
